Abubaker Bedri

Use of Dried-Blood-Spot Samples and In-House Assays To Identify Antiretroviral Drug Resistance in HIV-Infected Children in Resource-Constrained Settings

B. Simen, L. Khaki, D. Persaud, 2011, Journal of Clinical Microbiology.

Outcomes among HIV‐infected children initiating HIV care and antiretroviral treatment in Ethiopia

E. Abrams, C. Teasdale, M. Lamb, 2017, Tropical medicine & international health : TM & IH.

Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials

L. Moulton, R. Bollinger, G. Antelman, 2008, The Lancet.

Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission.

M. Hudgens, Allan W. Taylor, L. Mofenson, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.

S. Omer, D. Persaud, Y. Mengistu, 2011, AIDS research and human retroviruses.